ROCO
4431
Market cap19mUSD
Jul 09, Last price
17.20TWD
1D
-4.71%
1Q
0.29%
Jan 2017
-8.07%
IPO
37.38%
Name
Mytrex Health Technologies Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1990 and headquartered in Taoyuan, Taiwan, Mytrex Health Technologies, Inc. operates globally across Taiwan, Asia, Europe, and other international markets, specializing in the production and distribution of diverse non-woven fabrics. The company's offerings include advanced electrostatic filtration materials utilized in medical and industrial masks, as well as for various other filtration purposes. Additionally, Mytrex provides composite nonwoven products suitable for coolant and air filters, vacuum filter bags, HEPA and cabin filters, and water filtration compounds. Its portfolio also features thermal insulation materials for applications such as gloves, socks, shoes, hats, clothing, and mask insulation. Beyond manufacturing, Mytrex offers comprehensive services to hospitals, encompassing linen laundry and leasing, logistics support, and medical supply provisions. The company further extends its business to the sale of pharmaceuticals and medical hygiene items, alongside managing medical clothing products.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||